Search results
Oppenheimer ups Addus HomeCare shares target on IL rate hike By Investing.com
Investing.com· 2 days agoOn Friday, Oppenheimer adjusted its financial outlook for Addus HomeCare (NASDAQ:ADUS) shares, a...
Oppenheimer cuts Ventyx Biosciences stock target, holds Outperform rating By Investing.com
Investing.com· 3 days agoOppenheimer cuts Ventyx Biosciences stock target, holds Outperform rating
Keeping an Eye on Under Armour Inc
Knox Daily· 6 days agoIn the meantime, Oppenheimer downgraded its Under Armour Inc [UAA] rating to a Perform from a an Outperform in a research note...2024. It rated UAA as “an Underweight” which ...
Guidewire shares target raised to $140 at Oppenheimer on strong ARR growth By Investing.com
Investing.com· 4 days agoOn Wednesday, Oppenheimer adjusted its outlook on Guidewire (NYSE:GWRE), increasing the price target...
Lavoro F3Q24 results pressured by delayed sales; shares target cut by Oppenheimer By Investing.com
Investing.com· 5 days agoTuesday, Oppenheimer adjusted its outlook on shares of Lavoro (NASDAQ:LVRO), reducing the price...
Adobe shares target cut by Oppenheimer, bullish on mixed trends By Investing.com
Investing.com· 3 days agoOn Thursday, Oppenheimer maintained an Outperform rating on Adobe (NASDAQ:ADBE) stock but lowered...
Pick of the Month: Samsung delivers Dolby Atmos bliss while Luxman’s Swiss Army knife amp breaks the...
What Hi-Fi? via Yahoo News· 1 day agoWhether it was booming desert scenes in Dune, or subtle dialogue in quiet Oppenheimer moments, the...
9 new to Prime Video movies with 90% or higher on Rotten Tomatoes
Tom's Guide via Yahoo News· 3 days agoOne of the biggest movies of last year — second only to “Barbie” — it’s director Christopher...
IFF's Focus On Health And Environment Set To Drive Stock Momentum, Says Analyst - Intl Flavors &...
Benzinga· 2 days agoOppenheimer initiates coverage on IFF at Outperform rating with $116 price target. Analyst sees...
Corbus Pharmaceuticals shares rally on raised price target, Outperform rating By Investing.com
Investing.com· 6 days agoOppenheimer has raised the price target on Corbus Pharmaceuticals (NASDAQ:CRBP) shares to $80 from...
